Dermatology · Akron, OH
NPI
1518927482
Since 2006
Specialty
Dermatology
Code 207N00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
One Park West Blvd., Suite 370
Akron, OH, 44320
Phone (330) 835-9158
Groups this clinician bills Medicare through
Medicare paid, 2024
$19K
340 services
Medicare patients, 2024
113
Average age 72
Drug cost, 2024
$3.1M
1,541 prescriptions
Company payments, 2025
$251
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Julie A Mark was code 99214 (office e&m - established), 122 times for 86 patients. In total Julie A Mark billed 340 services in 20 codes, and Medicare paid $19K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-09-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 122 | 86 | $81.82 | $9,982 |
| 17003 Destruction Skin Lesion | Office | 54 | 14 | $4.66 | $252 |
| 11102 Skin Biopsy | Office | 35 | 29 | $64.92 | $2,272 |
| 17000 Destruction Skin Lesion | Office | 29 | 22 | $40.57 | $1,176 |
| 99213 Office E&M - Established | Office | 23 | 22 | $56.23 | $1,293 |
| 99204 Office E&M - New | Office | 14 | 14 | $117.00 | $1,638 |
| 11103 Skin Biopsy | Office | 14 | 13 | $36.87 | $516 |
By year: 2022 $19K for 337 services; 2023 $19K for 326 services; 2024 $19K for 340 services.
Medicare prescription drug claims, 2024
In 2024, the drug Julie A Mark prescribed most often to Medicare patients was Clobetasol Propionate, with 174 prescriptions and refills. In total Julie A Mark wrote 1,541 Medicare prescriptions that cost $3.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Clobetasol Propionate Generic | 174 | 206 | 49 | $10K |
| Triamcinolone Acetonide Generic | 121 | 127 | 57 | $1,813 |
| Ketoconazole Generic | 115 | 128 | 31 | $1,521 |
| Otezla Apremilast | 101 | 101 | 12 | $486K |
| Dupixent Pen Dupilumab | 84 | 84 | 11 | $311K |
| Clindamycin Phosphate Generic | 62 | 70 | 12 | $3,652 |
| Ciclopirox Generic | 60 | 73 | 12 | $3,543 |
| Acitretin Generic | 45 | 47 | Under 11 | $15K |
| Ammonium Lactate Generic | 41 | 60 | Under 11 | $1,701 |
| Fluorouracil Generic | 36 | 47 | 28 | $2,309 |
| Vtama Tapinarof | 36 | 36 | Under 11 | $50K |
| Clobetasol Emollient Clobetasol Propionate/Emoll | 29 | 38 | 13 | $3,792 |
| Cosentyx Sensoready (2 Pens) Secukinumab | 29 | 29 | Under 11 | $200K |
| Doxycycline Hyclate Generic | 28 | 34 | Under 11 | $775 |
| Valacyclovir Valacyclovir Hcl | 27 | 27 | Under 11 | $694 |
Brand drugs: 481 claims; generic drugs: 1,060 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Julie A Mark $251 ($251 in general payments such as food, travel and fees) from 5 companies. The largest payer was Novartis Pharmaceuticals Corporation with $87.65.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.